PMC:7283670 / 66534-66792 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7283670","sourcedb":"PMC","sourceid":"7283670","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7283670","text":"ys. thalidomide: 100 mg/d qn for 14 days II Primary (up to 28 days): time to clinical improvement\nSecondary (up to 28 days): clinical status (days 7, 14, 21, and 28), time to hospital discharge or NEWS2 (National Early Warning Score 2) of ≤2 maintained for","divisions":[{"label":"td","span":{"begin":42,"end":44}},{"label":"p","span":{"begin":46,"end":99}}],"tracks":[{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T205","span":{"begin":4,"end":15},"obj":"Chemical"},{"id":"T206","span":{"begin":42,"end":44},"obj":"Chemical"}],"attributes":[{"id":"A205","pred":"chebi_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/CHEBI_9513"},{"id":"A206","pred":"chebi_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"},{"subj":"T205","pred":"source","obj":"LitCovid-PD-CHEBI"},{"subj":"T206","pred":"source","obj":"LitCovid-PD-CHEBI"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T656","span":{"begin":17,"end":99},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T656","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CHEBI","color":"#d993ec","default":true},{"id":"LitCovid-sentences","color":"#93ecbf"}]}]}}